Skip to main content
Erschienen in: Diabetology International 1/2022

05.09.2021 | Original Article

Vomiting and hyperkalemia are novel clues for emergency room diagnosis of type 1 diabetic ketoacidosis: a retrospective comparison between diabetes types

verfasst von: Tomoko Takai, Yuko Okada, Reiko Takebe, Takehiro Nakamura

Erschienen in: Diabetology International | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Diabetic ketoacidosis (DKA) is an acute life-threatening complication in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). Causes, underlying pathophysiology, and mortality differ significantly by diabetes type, which initial treatment is dependent on, but few reports on these differences are available. This study aimed to clarify differences in clinical characteristics between the diabetes types to extract important clinical clues for preventing DKA and ensuring appropriate initial treatment in the emergency room.

Methods

We retrospectively analyzed the clinical presentation of 24 T1DM patients and 13 T2DM patients admitted with DKA to Kobe City Medical Center West Hospital between April 2006 and December 2018.

Results

In T1DM, the main causes were insulin omission and new onset, and important factors were also misdiagnosis with consequent inappropriate insulin prescription and older age with dementia. In T2DM, the main causes were infection and excessive soft drink consumption. For all soft drink ketosis patients, this was the first presentation of diabetes. The main complaint differed between diabetes types. Vomiting was a characteristic symptom in T1DM DKA; most T2DM DKA patients presented with generalized malaise or decreased level of consciousness. On blood examination, serum potassium level was higher and HbA1c was lower in T1DM DKA.

Conclusions

To prevent DKA, it is important to provide social support for elderly patients with T1DM DKA and lifestyle intervention for younger T2DM or obese patients. Vomiting and serum potassium levels contribute to the classification of diabetes type and subsequent initial treatment in the emergency room.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Karslioglu French E, Donihi AC, Korytkowski MT. Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ. 2019;29(365):11114. Karslioglu French E, Donihi AC, Korytkowski MT. Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ. 2019;29(365):11114.
2.
Zurück zum Zitat Siwakoti K, Giri S, Kadaria D. Cerebral edema among adults with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome: incidence, characteristics, and outcomes. J Diabetes. 2017;9:208–9.CrossRef Siwakoti K, Giri S, Kadaria D. Cerebral edema among adults with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome: incidence, characteristics, and outcomes. J Diabetes. 2017;9:208–9.CrossRef
3.
Zurück zum Zitat Desai D, Mehta D, Mathias P, Menon G, Schubart UK. Health care utilization and burden of diabetic ketoacidosis in the US over the past decade: a nationwide analysis. Diabetes Care. 2018;41:1631–8.CrossRef Desai D, Mehta D, Mathias P, Menon G, Schubart UK. Health care utilization and burden of diabetic ketoacidosis in the US over the past decade: a nationwide analysis. Diabetes Care. 2018;41:1631–8.CrossRef
4.
Zurück zum Zitat Zhong VW, Juhaeri J, Mayer-Davis EJ. Trends in hospital admission for diabetic ketoacidosis in adults with type 1 and type 2 diabetes in England, 1998–2013: a retrospective cohort study. Diabetes Care. 2018;41:1870–7.CrossRef Zhong VW, Juhaeri J, Mayer-Davis EJ. Trends in hospital admission for diabetic ketoacidosis in adults with type 1 and type 2 diabetes in England, 1998–2013: a retrospective cohort study. Diabetes Care. 2018;41:1870–7.CrossRef
5.
Zurück zum Zitat Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32:1335–43.CrossRef Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32:1335–43.CrossRef
6.
Zurück zum Zitat Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A. Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality - United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2018;67:362–5.CrossRef Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A. Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality - United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2018;67:362–5.CrossRef
7.
Zurück zum Zitat Nyenwe EA, Kitabchi AE. The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management. Metabolism. 2016;65:507–21.CrossRef Nyenwe EA, Kitabchi AE. The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management. Metabolism. 2016;65:507–21.CrossRef
8.
Zurück zum Zitat Kawasaki E, Maruyama T, Imagawa A, Awata T, Ikegami H, Uchigata Y, Osawa H, Kawabata Y, Kobayashi T, Shimada A, Shimizu I, Takahashi K, Nagata M, Makino H, Hanafusa T. Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): report of the committee of Japan diabetes society on the research of fulminant and acute-onset type 1 diabetes mellitus. J Diabetes Investig. 2014;5:115–8.CrossRef Kawasaki E, Maruyama T, Imagawa A, Awata T, Ikegami H, Uchigata Y, Osawa H, Kawabata Y, Kobayashi T, Shimada A, Shimizu I, Takahashi K, Nagata M, Makino H, Hanafusa T. Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): report of the committee of Japan diabetes society on the research of fulminant and acute-onset type 1 diabetes mellitus. J Diabetes Investig. 2014;5:115–8.CrossRef
9.
Zurück zum Zitat Modi A, Agrawal A, Morgan F. Euglycemic diabetic ketoacidosis: a review. Curr Diabetes Rev. 2017;13:315–21.CrossRef Modi A, Agrawal A, Morgan F. Euglycemic diabetic ketoacidosis: a review. Curr Diabetes Rev. 2017;13:315–21.CrossRef
10.
Zurück zum Zitat Yamada K, Nonaka K. Diabetic ketoacidosis in young obese Japanese men. Diabetes Care. 1996;19:671.CrossRef Yamada K, Nonaka K. Diabetic ketoacidosis in young obese Japanese men. Diabetes Care. 1996;19:671.CrossRef
11.
Zurück zum Zitat Iwasaki Y, Hamamoto Y, Kawasaki Y, Ikeda H, Honjo S, Wada Y, Koshiyama H. Japanese cases of acute onset diabetic ketosis without acidosis in the absence of glutamic acid decarboxylase autoantibody. Endocrine. 2010;37:286–8.CrossRef Iwasaki Y, Hamamoto Y, Kawasaki Y, Ikeda H, Honjo S, Wada Y, Koshiyama H. Japanese cases of acute onset diabetic ketosis without acidosis in the absence of glutamic acid decarboxylase autoantibody. Endocrine. 2010;37:286–8.CrossRef
12.
Zurück zum Zitat Wang ZH, Kihl-Selstam E, Eriksson JW. Ketoacidosis occurs in both Type 1 and Type 2 diabetes-a population-based study from Northern Sweden. Diabet Med. 2008;25:867–70.CrossRef Wang ZH, Kihl-Selstam E, Eriksson JW. Ketoacidosis occurs in both Type 1 and Type 2 diabetes-a population-based study from Northern Sweden. Diabet Med. 2008;25:867–70.CrossRef
13.
Zurück zum Zitat Newton CA, Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences. Arch Intern Med. 2004;164:1925–31.CrossRef Newton CA, Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences. Arch Intern Med. 2004;164:1925–31.CrossRef
14.
Zurück zum Zitat Ko SH, Lee WY, Lee JH, Kwon HS, Lee JM, Kim SR, Moon SD, Song KH, Han JH, Ahn YB, Yoo SJ, Son HY. Clinical characteristics of diabetic ketoacidosis in Korea over the past two decades. Diabet Med. 2005;22:466–9.CrossRef Ko SH, Lee WY, Lee JH, Kwon HS, Lee JM, Kim SR, Moon SD, Song KH, Han JH, Ahn YB, Yoo SJ, Son HY. Clinical characteristics of diabetic ketoacidosis in Korea over the past two decades. Diabet Med. 2005;22:466–9.CrossRef
15.
Zurück zum Zitat Brandstaetter E, Bartal C, Sagy I, Jotkowitz A, Barski L. Recurrent diabetic ketoacidosis. Arch Endocrinol Metab. 2019;63:531–5.PubMed Brandstaetter E, Bartal C, Sagy I, Jotkowitz A, Barski L. Recurrent diabetic ketoacidosis. Arch Endocrinol Metab. 2019;63:531–5.PubMed
16.
Zurück zum Zitat Lee MH, Calder GL, Santamaria JD, MacIsaac RJ. Diabetic ketoacidosis in adult patients: an audit of factors influencing time to normalisation of metabolic parameters. Intern Med J. 2018;48:529–34.CrossRef Lee MH, Calder GL, Santamaria JD, MacIsaac RJ. Diabetic ketoacidosis in adult patients: an audit of factors influencing time to normalisation of metabolic parameters. Intern Med J. 2018;48:529–34.CrossRef
17.
Zurück zum Zitat Weinert LS, Scheffel RS, Severo MD, Cioffi AP, Teló GH, Boschi A, Schaan BD. Precipitating factors of diabetic ketoacidosis at a public hospital in a middle-income country. Diabetes Res Clin Pract. 2012;96:29–34.CrossRef Weinert LS, Scheffel RS, Severo MD, Cioffi AP, Teló GH, Boschi A, Schaan BD. Precipitating factors of diabetic ketoacidosis at a public hospital in a middle-income country. Diabetes Res Clin Pract. 2012;96:29–34.CrossRef
18.
Zurück zum Zitat Umpierrez G, Korytkowski M. Diabetic emergencies -ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12:222–32.CrossRef Umpierrez G, Korytkowski M. Diabetic emergencies -ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12:222–32.CrossRef
19.
Zurück zum Zitat Wu XY, She DM, Wang F, Guo G, Li R, Fang P, Li L, Zhou Y, Zhang KQ, Xue Y. Clinical profiles, otcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital based analysis over a 6-year period. BMC Endocr Disord. 2020;20:182–219.CrossRef Wu XY, She DM, Wang F, Guo G, Li R, Fang P, Li L, Zhou Y, Zhang KQ, Xue Y. Clinical profiles, otcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital based analysis over a 6-year period. BMC Endocr Disord. 2020;20:182–219.CrossRef
20.
Zurück zum Zitat Bao YK, Ma J, Ganesan VC, McGill JB. Mistaken identity: missed diagnosis of Type1 diabetes in an older adult. Med Res Arch. 2019;7:1962–6.PubMedPubMedCentral Bao YK, Ma J, Ganesan VC, McGill JB. Mistaken identity: missed diagnosis of Type1 diabetes in an older adult. Med Res Arch. 2019;7:1962–6.PubMedPubMedCentral
21.
Zurück zum Zitat Onda Y, Sugihara S, Ogata T, Yokoya S, Yokoyama T, Tajima N, Type 1 Diabetes (T1D) Study Group. Incidence and prevalence of childhood-onset Type1 diabetes in Japan: the T1D study. Diabet Med. 2017;34:909–15.CrossRef Onda Y, Sugihara S, Ogata T, Yokoya S, Yokoyama T, Tajima N, Type 1 Diabetes (T1D) Study Group. Incidence and prevalence of childhood-onset Type1 diabetes in Japan: the T1D study. Diabet Med. 2017;34:909–15.CrossRef
22.
Zurück zum Zitat Tauschmann M, Hermann JM, Freiberg C, Papsch M, Thon A, Heidtmann B, Placzeck K, Agena D, Kapellen TM, Schenk B, Wolf J, Danne T, Rami-Merhar B, Holl RW, DPV Initiative. Reduction in diabetic ketoacidosis and severe hypoglycemia in pediatric Type1 diabetes during the first year of continuous glucose monitoring: a multicenter analysis of 3,553 subjects from the DPV registry. Diabetes Care. 2020;43:e40–2.CrossRef Tauschmann M, Hermann JM, Freiberg C, Papsch M, Thon A, Heidtmann B, Placzeck K, Agena D, Kapellen TM, Schenk B, Wolf J, Danne T, Rami-Merhar B, Holl RW, DPV Initiative. Reduction in diabetic ketoacidosis and severe hypoglycemia in pediatric Type1 diabetes during the first year of continuous glucose monitoring: a multicenter analysis of 3,553 subjects from the DPV registry. Diabetes Care. 2020;43:e40–2.CrossRef
23.
Zurück zum Zitat Charleer S, Mathieu C, Nobels F, De Block CD, Radermecker RP, Hermans MP, Taes Y, Vercammen C, T’Sjoen G, Crenier L, Fieuws S, Keymeulen B, Gillard P, RESCUE Trial Investigators. Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study. J Clin Endocrinol Metab. 2018;103:1224–32.CrossRef Charleer S, Mathieu C, Nobels F, De Block CD, Radermecker RP, Hermans MP, Taes Y, Vercammen C, T’Sjoen G, Crenier L, Fieuws S, Keymeulen B, Gillard P, RESCUE Trial Investigators. Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study. J Clin Endocrinol Metab. 2018;103:1224–32.CrossRef
24.
Zurück zum Zitat Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, et al. Six-month randomized, multicenter trial of closed-loop control in Type1 diabetes. N Engl J Med. 2019;381:1707–17.CrossRef Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, Laffel LM, Levy CJ, Pinsker JE, Wadwa RP, et al. Six-month randomized, multicenter trial of closed-loop control in Type1 diabetes. N Engl J Med. 2019;381:1707–17.CrossRef
25.
Zurück zum Zitat Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, Brazg RL, Ilany J, Slover RH, Anderson SM, Bergenstal RM, Grosman B, Roy A, Cordero TL, Shin J, Lee SW, Kaufman FR, Anderson SM, et al. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2017;19:155–63.CrossRef Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, Brazg RL, Ilany J, Slover RH, Anderson SM, Bergenstal RM, Grosman B, Roy A, Cordero TL, Shin J, Lee SW, Kaufman FR, Anderson SM, et al. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2017;19:155–63.CrossRef
26.
Zurück zum Zitat Matsuura N, Amemiya S, Sugihara S, Urakami T, Kikuchi N, Kato H, Yodo Y, Study Group of the Pediatric Clinical Trial of Metformin in Japan. Metformin monotherapy in children and adolescents with type 2 diabetes mellitus in Japan. Diabetol Int. 2019;10:51–7.CrossRef Matsuura N, Amemiya S, Sugihara S, Urakami T, Kikuchi N, Kato H, Yodo Y, Study Group of the Pediatric Clinical Trial of Metformin in Japan. Metformin monotherapy in children and adolescents with type 2 diabetes mellitus in Japan. Diabetol Int. 2019;10:51–7.CrossRef
27.
Zurück zum Zitat Spurr S, Bally J, Bullin C, Allan D, McNair E. The prevalence of undiagnosed prediabetes/type 2 diabetes, prehypertension/hypertension and obesity among ethnic groups of adolescents in Western Canada. BMC Pediatr. 2020;20:31.CrossRef Spurr S, Bally J, Bullin C, Allan D, McNair E. The prevalence of undiagnosed prediabetes/type 2 diabetes, prehypertension/hypertension and obesity among ethnic groups of adolescents in Western Canada. BMC Pediatr. 2020;20:31.CrossRef
28.
Zurück zum Zitat Middleton TL, Constantino MI, Molyneaux L, D’Souza M, Twigg SM, Wu T, Yue DK, Zoungas S, Wong J. Young- onset Type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complications. Diabet Med. 2020;37:991–9.CrossRef Middleton TL, Constantino MI, Molyneaux L, D’Souza M, Twigg SM, Wu T, Yue DK, Zoungas S, Wong J. Young- onset Type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complications. Diabet Med. 2020;37:991–9.CrossRef
29.
Zurück zum Zitat Tan H, Zhou Y, Yu Y. Characteristics of diabetic ketoacidosis in Chinese adults and adolescents—a teaching hospital-based analysis. Diabetes Res Clin Pract. 2012;97:306–12.CrossRef Tan H, Zhou Y, Yu Y. Characteristics of diabetic ketoacidosis in Chinese adults and adolescents—a teaching hospital-based analysis. Diabetes Res Clin Pract. 2012;97:306–12.CrossRef
30.
Zurück zum Zitat Alourfi Z, Homsi H. Precipitating factors, outcomes, and recurrence of diabetic ketoacidosis at a university hospital in Damascus. Avicenna J Med. 2015;5:11–5.CrossRef Alourfi Z, Homsi H. Precipitating factors, outcomes, and recurrence of diabetic ketoacidosis at a university hospital in Damascus. Avicenna J Med. 2015;5:11–5.CrossRef
31.
Zurück zum Zitat Ahuja W, Kumar N, Kumar S, Rizwan A. Precipitating Risk Factors, clinical presentation, and outcome of diabetic ketoacidosis in patients with Type 1 diabetes. Cureus. 2019;11:e4789.PubMedPubMedCentral Ahuja W, Kumar N, Kumar S, Rizwan A. Precipitating Risk Factors, clinical presentation, and outcome of diabetic ketoacidosis in patients with Type 1 diabetes. Cureus. 2019;11:e4789.PubMedPubMedCentral
32.
Zurück zum Zitat Canziani BC, Uestuener P, Fossali EF, Lava SAG, Bianchetti MG, Agostoni C, Milani GP. Clinical practice: nausea and vomiting in acute gastroenteritis: physiopathology and management. Eur J Pediatr. 2018;177:1–5.CrossRef Canziani BC, Uestuener P, Fossali EF, Lava SAG, Bianchetti MG, Agostoni C, Milani GP. Clinical practice: nausea and vomiting in acute gastroenteritis: physiopathology and management. Eur J Pediatr. 2018;177:1–5.CrossRef
33.
Zurück zum Zitat Kamata Y, Takano K, Kishihara E, Watanabe M, Ichikawa R, Shichiri M. Distinct clinical characteristics and therapeutic modalities for diabetic ketoacidosis in Type 1 and type 2 diabetes mellitus. J Diabetes Complic. 2017;31:468–72.CrossRef Kamata Y, Takano K, Kishihara E, Watanabe M, Ichikawa R, Shichiri M. Distinct clinical characteristics and therapeutic modalities for diabetic ketoacidosis in Type 1 and type 2 diabetes mellitus. J Diabetes Complic. 2017;31:468–72.CrossRef
34.
Zurück zum Zitat Balmier A, Dib F, Serret-Larmande A, De Montmollin E, Pouyet V, Sztrymf B, Megarbane B, Thiagarajah A, Dreyfuss D, Ricard JD, Roux D. Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study. Ann Intensive Care. 2019;9:91.CrossRef Balmier A, Dib F, Serret-Larmande A, De Montmollin E, Pouyet V, Sztrymf B, Megarbane B, Thiagarajah A, Dreyfuss D, Ricard JD, Roux D. Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study. Ann Intensive Care. 2019;9:91.CrossRef
Metadaten
Titel
Vomiting and hyperkalemia are novel clues for emergency room diagnosis of type 1 diabetic ketoacidosis: a retrospective comparison between diabetes types
verfasst von
Tomoko Takai
Yuko Okada
Reiko Takebe
Takehiro Nakamura
Publikationsdatum
05.09.2021
Verlag
Springer Singapore
Erschienen in
Diabetology International / Ausgabe 1/2022
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-021-00539-w

Weitere Artikel der Ausgabe 1/2022

Diabetology International 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.